Solid Biosciences Inc Debt/Equity
What is the Debt/Equity of Solid Biosciences Inc?
The Debt/Equity of Solid Biosciences Inc is 0.30
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on NASDAQ compared to Solid Biosciences Inc
What does Solid Biosciences Inc do?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Companies with debt/equity similar to Solid Biosciences Inc
- West Fraser Timber Co has Debt/Equity of 0.30
- West Fraser Timber Co has Debt/Equity of 0.30
- Radcom has Debt/Equity of 0.30
- Lancaster Colony has Debt/Equity of 0.30
- Ikonics has Debt/Equity of 0.30
- Riddhi Siddhi Gluco Biols has Debt/Equity of 0.30
- Solid Biosciences Inc has Debt/Equity of 0.30
- Infibeam Avenues has Debt/Equity of 0.30
- TDG Gold has Debt/Equity of 0.30
- Motif Bio plc has Debt/Equity of 0.30
- Matinas Biopharma Inc has Debt/Equity of 0.30
- Sun.King Power Electronics has Debt/Equity of 0.30
- Yunji has Debt/Equity of 0.30